Author/Authors :
Alyasin, Soheila Department of Allergy and Clinical Immunology - Nemazee Hospital - Shiraz , Reza Amin, Rezq Department of Allergy and Clinical Immunology - Nemazee Hospital - Shiraz , Fazel, Ali Department of Allergy and Clinical Immunology - Nemazee Hospital - Shiraz , Nabavizadeh, Seyed Hesamedin Department of Allergy and Clinical Immunology - Nemazee Hospital - Shiraz , Esmaeilzadeh, Hossein Department of Allergy and Clinical Immunology - Nemazee Hospital - Shiraz , Babaei, Maryam Department of Allergy Research Center - Shiraz University of Medical Sciences - Shiraz , Karimi, Mohammad Hossein Department of Allergy Research Center - Shiraz University of Medical Sciences - Shiraz
Abstract :
Background: Asthma is the chronic inflammation of airways characterized by
eosinophilic infiltration, mucus overproduction, airway hyper-responsiveness and
airway remodeling. These changes are induced mostly by cytokines which are produced
by T helper (Th) 2 cells. Recently, the role of interleukin-23 (IL-23) in the pathogenesis
of adultallergic asthma has been studied. Objective: To explore IL-23 serum levels and
its expression in persistent asthma compared with healthy children younger than five
years old. Method: Blood samples of 40 children with mild and severe persistent
asthma were compared to 34 healthy children regarding IL-23 serum levels and gene
expression using enzyme-linked immunosorbentassay (ELISA) and real time
quantitative polymerase chain reaction (PCR). Results: The IL-23 gene expression level
was significantly different in the 25 children with mild persistent asthma and the 15
children with severe persistent asthma compared to the control group (p=0.001).There
was no significant difference in IL-23 gene expression level between the two groups of
patients with mild and severe persistent asthma. A significant difference was seen in IL-
23 serum levels between the 25 children with persistent asthma and control group
(p=0.002).Conclusion: For pre-school children with history and physical exam in favor
of asthma which cannot be tested by spirometry, IL-23 serum levels may be an auxiliary
biomarker for the diagnosis of asthma.